Factors influencing the parotid function in nasopharyngeal carcinoma treated with parotid-sparing radiotherapy

Japanese Journal of Clinical Oncology

Volumn 36, Issue 10, 2006, Pages 626-631

  Liu, Wen Shan ^a,b   Lee, Steve Pai Hsun ^c   Lee, Jong Kang ^a   Su, Mao Chang ^a   Chen, Gin Den ^b   Lee, Hong Shen ^b   Lee, Huei ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intensity modulated radiotherapy; Nasopharyngeal carcinoma; Parotid sparing radiotherapy; Sialoscintigraphy; Xerostomia

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHI SQUARE TEST; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; NASOPHARYNX CARCINOMA; ORGAN PRESERVATION; PAROTID GLAND; RANK SUM TEST; SALIVARY GLAND FUNCTION; SCINTIGRAPHY; THREE DIMENSIONAL IMAGING; WILCOXON SIGNED RANKS TEST; XEROSTOMIA;

ADULT; AGED; BRACHYTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PAROTID GLAND; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; XEROSTOMIA;

EID: 33750721343     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl098     Document Type: Article

References (24)

1. Cheng SH, Jian JJ, Tsai SY. Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 1998;41:755-62.
2. Sanguineti G, Geara FB, Garden AS, Susan TL, Ang KK, William HM, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control. Int J Radiat Oncol Biol Phys 1997;37:985-96.
3. Nishioka T, Shirato H, Arimoto T, Masanori K, Toshihiro K, et al. Reduction of radiation-induced xerostomia in nasopharyngeal carcinoma using CT simulation with laser patient marking and three-field irradiation technique. Int J Radiat Oncol Biol Phys 1997;38:705-12.
4. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, et al. Oral pilocarpine for post-irradiation xerotomia in patients with head and neck cancer. N Engl J Med 1993;329:390-5.
5. Hazuka MB, Martel MK, Marsh L. Lichter AS, Wolf GT. Preservation of parotid function after external beam irradiation in head and neck cancer patients: A feasibility study using 3-dimensional treatment planning. Int J Radiat Oncol Biol Phys 1993;27:731-7.
6. Roesink JM, Moerland MA, Battermann JJ, Hordijk GJ, Terhaard CH, et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 2001;51:938-46.
7. Verhey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol 1999;9:78-98.
8. Cheng JCH, Chao KSC, Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 2001;96:126-31.
9. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatemtn plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000;48:329-37.
10. Butler EB, The BS, Grant WH, Uhl BM, Kuppersmith RB, Chiu JK, et al. SMART (Simultaneous modulated accelerated radiation therapy) boost: A new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 1999;45:21-32.
11. Chao KSC, Low DA, Perez CA, Purdy JA. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience. Int J Cancer 2000;90:92-103.
12. Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The university of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2000;48:711-22.
13. Lee N, Xia P, Quivey JM, Sultanem K, Ian P, Clayton A, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22.
14. Fleming ID, Cooper JS, Murphy GP, Sullivan BO, Sobin LH, Yarbro JW, et al. AJCC Manual for Staging of Cancer, 5th edn. Philadelphia: JB Lippincott 1997; 31-9.
15. Liu WS, Su MC, Wu MF, Tseng HC, Kuo HC. Nasopharyngeal carcinoma treated with precision-oriented radiation therapy techniques including intensity-modulated radiotherapy: Preliminary results. Kaohsiung J Med Sci 2004;20:49-55.
16. Mohan R, Wu Q, Maning M, Rupert SU. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000;46:619-30.
17. Tsujii H. Quantitiativ dose-response analysis of salivary function following radiotherapy using sequential RI-sialography. Int J Radiat Oncol Biol Phys 1985;11:1603-12.
18. Pavy JJ, Denckamp J, Letschert J, Littbrand B, Mornex F, Bernier J, et al. Late effect toxicity scoring: The SOMA scale. Radiother Oncol 1995;35:11-60.
19. Mira JG, Wescott WB, Starcke EN. Shannon IL. Some factors influencing salivary function when treating with radiotherapy. Int J Radiat Oncol Biol Phys 1981;7:535-41.
20. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship AJ. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-87.
21. Chao KSC, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 2001;49: 907-16.
22. Liem IH, Olmos RA, Balm AJ, Keus RB, van Tinteren H, Takes RP, et al. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumors. Eur J Nucl Med 1996;23:1485-90.
23. Ng MK, Porcedduy SV, Milnerz AD, Corry J, Hornby C, Hope G, et al. Parotid-sparing radiotherapy: Does it really reduce xerostomia? Clinl Oncol 2005;17:610-17.
24. Jen YM, Shih R, Lin YS, Su WF, Ku CH, Chang CS, et al. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: A dosimetric and clinical comparison with conventional radiotherapy. Radiother Oncol 2005;75:204-9.